drugset / Trial / NCT03054194
Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730
RandomizedParallel-groupTriple-blindTreatment
Summary
Study E2730-A001-001 is a first-in-human, sequential ascending single dose, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics (PK) of a single oral dose of E2730 in healthy participants.
Timeline
- Start
- 2017-01-31
- Primary completion
- 2017-03-02
- Completion
- 2017-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E2730 | Unknown | — | Oral |
Indications
No indication recorded.